A number of studies support the use of GLP-1 for weight loss
Proceeds from the Series A preferred stock issuance will be used to advance the Companys therapeutic product candidate, mizagliflozin, into Phase II clinical trials
Fortunately for most GLP-1 users, the gastrointestinal side effects are mild to moderate in severity, generally tolerable and tend to improve with time, especially with careful and slow dose titration
When side effects do occur, they tend to be minor and include symptoms such as nausea, vomiting, gastrointestinal issues, and diarrhea
coordinate with PlexusDx to have your next injection scheduled right on time so you don't lose momentum in your weight loss journey
The TrimRx Approach: Science-Backed, Personalized Weight Loss Understanding the limitations and risks of Ozempic patches highlights the critical importance of choosing safe, effective, and medically supervised weight loss solutions